Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Accustem Sciences Inc

ACUT.PK ✓ COMPLIANT ☆ Track — members

OTC Pink · Healthcare · Medical Equipment, Supplies & Distribution ·

USA Micro Cap Analyst: N/A

Last Close

$0.00

▲ +0.00%

Market Cap $4.43M · Vol 8.00M

Key Metrics

P/E Ratio

N/A

FWD: 0.22

Market Cap

$4.43M

Micro Cap

Div Yield

N/A

Annual dividend

EPS Growth

N/A

YoY

RSI (14)

50.00

Momentum

Beta

0.37

vs Market

52W High

$0.00

N/A below

52W Low

$0.00

N/A above

Volume

8.00M

Avg 0

P/B

2.34

Price-to-book

ROE

N/A

Return on equity

Free Float

100.00%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Accustem Sciences Inc (ACUT.PK) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does ACUT.PK pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

+0.00%

YTD

+0.00%

-94.22%

-99.81%

Financials & Valuation

TTM · Annual

Total Revenue	$317.22M
Net Income	$-355,378,427.00
Revenue Growth (YoY)	-82.37%
Gross Margin	28.00%
Operating Margin	-78.56%
Net Profit Margin	-112.03%
ROE	N/A
ROA · ROIC	-31.71% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	0.22
PEG Ratio	N/A
P/S	0.02
P/B	2.34
P/FCF	N/A
EPS Growth	N/A
Outstanding Shares	939.42M

Technical Indicators

50-Day SMA	$0.00
200-Day SMA	$0.00
RSI (14)	50.00
Beta	0.37
52-Week High	$0.00
52-Week Low	$0.00

Volume Today	8.00M
Avg Daily Volume (30D)	0
Relative Volume	N/Ax
Volatility (10D)	0.00
Volatility (30D)	0.00
Free Float	100.00%

Analyst Consensus

N/A

Current Price $0.00

Mean Target N/A

52W Low$0.00 52W High$0.00

Current

Target

$0.00 $0.00

Current Analyst target

· 0 analysts

Identifiers

ExchangeOTC Pink

FIGIBBG015QPWJ60

ISINUS00444A1016

CountryUnited States of America

Sub-IndustryMedical Equipment, Supplies & Distribution (NEC)

Earnings DateN/A

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

ABT Abbott Laboratories -0.42% MDT Medtronic PLC +1.15% COR Cencora Inc -1.86% 7741.T Hoya Corp -1.31% BDX Becton Dickinson and Co -1.54%

Company Profile

AccuStem Sciences, Inc. is a clinical-stage diagnostics company. It is focused on developing and commercializing a suite of genomic tests that support decision-making along the entire continuum of oncology care. It focuses on its proprietary genomic tests, MicroRNA Signature Classifier (MSC) for patients with lung nodules and StemPrintER for patients with early-stage breast cancer. The MSC test, a 24-micro-RNA (miRNA) assay designed to help determine whether lung nodules identified by low-dose computer tomography (LDCT) screening, are benign or malignant. StemPrintER, a 20-gene prognostic assay intended to predict the risk of distant recurrence (DR) in luminal (ER+/HER2-negative) breast cancer patients. The assay is developed to measure the stemness of tumors, or how much a tumor behaves like stem cells, which could indicate how likely a cancer is to recur or be resistant to standard treatments, ultimately impacting how patients are managed by their multidisciplinary care team.